Detalhe da pesquisa
1.
Neuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer's disease: An update.
Eur J Neurosci
; 55(5): 1322-1343, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35083791
2.
[18F]THK5317 imaging as a tool for predicting prospective cognitive decline in Alzheimer's disease.
Mol Psychiatry
; 26(10): 5875-5887, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32616831
3.
Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AßPParc and PSEN1DE9.
Mol Psychiatry
; 26(10): 5609-5619, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32581318
4.
Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study.
Alzheimers Dement
; 2022 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35715930
5.
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study.
Alzheimers Dement
; 16(5): 750-758, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32281303
6.
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease.
Eur J Nucl Med Mol Imaging
; 46(5): 1152-1163, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30610252
7.
Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease.
Alzheimers Dement
; 14(5): 652-663, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29268078
8.
Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.
Brain
; 139(Pt 3): 922-36, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26813969
9.
Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm.
Eur J Nucl Med Mol Imaging
; 43(9): 1686-99, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26996778
10.
Case report of Lewy body disease mimicking Creutzfeldt-Jakob disease in a 44-year-old man.
BMC Neurol
; 16: 122, 2016 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27475058
11.
Insight on AV-45 binding in white and grey matter from histogram analysis: a study on early Alzheimer's disease patients and healthy subjects.
Eur J Nucl Med Mol Imaging
; 41(7): 1408-18, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24573658
12.
Associations Between Blood Nutritional Biomarkers and Cerebral Amyloid-ß: Insights From the COGFRAIL Cohort Study.
J Gerontol A Biol Sci Med Sci
; 79(1)2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879623
13.
Documenting the de-identification process of clinical and imaging data for AI for health imaging projects.
Insights Imaging
; 15(1): 130, 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38816658
14.
MR, (18)F-FDG, and (18)F-AV45 PET correlate with AD PSEN1 original phenotype.
Alzheimer Dis Assoc Disord
; 27(1): 91-4, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-22517194
15.
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial.
JAMA Neurol
; 80(6): 548-557, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37155177
16.
The impact of a multi-domain intervention on cerebral glucose metabolism: analysis from the randomized ancillary FDG PET MAPT trial.
Alzheimers Res Ther
; 12(1): 134, 2020 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33076983
17.
Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer's Disease: A PET Study.
J Alzheimers Dis
; 73(4): 1607-1614, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31958082
18.
Posterior Cortical Atrophy: Does Complaint Match the Impairment? A Neuropsychological and FDG-PET Study.
Front Neurol
; 10: 1010, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31616363
19.
Cognitive changes of older adults with an equivocal amyloid load.
J Neurol
; 266(4): 835-843, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30689016
20.
Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study.
Alzheimers Res Ther
; 10(1): 45, 2018 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29747683